<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Positive Steps Toward the Next Obesity Drug Approval</title>
	<atom:link href="http://blog.pharmtech.com/2010/12/23/positive-steps-toward-the-next-obesity-drug-approval/feed/" rel="self" type="application/rss+xml" />
	<link>http://blog.pharmtech.com/2010/12/23/positive-steps-toward-the-next-obesity-drug-approval/</link>
	<description>The blog of Pharmaceutical Technology magazine</description>
	<lastBuildDate>Thu, 09 May 2013 23:30:55 -0400</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.4</generator>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>By: Diabetes</title>
		<link>http://blog.pharmtech.com/2010/12/23/positive-steps-toward-the-next-obesity-drug-approval/comment-page-1/#comment-34103</link>
		<dc:creator>Diabetes</dc:creator>
		<pubDate>Thu, 23 Dec 2010 19:08:14 +0000</pubDate>
		<guid isPermaLink="false">http://blog.pharmtech.com/?p=3747#comment-34103</guid>
		<description>The FDA panel also stated that Contrave did not provide enough evidence that the drug was safe for the heart. The panel vote 11 to 8 that more research must be submitted (testing on the elderly) that the drug wil not cause heart trouble. This is a promising positive step but the jury is still out on the safety of Contrave</description>
		<content:encoded><![CDATA[<p>The FDA panel also stated that Contrave did not provide enough evidence that the drug was safe for the heart. The panel vote 11 to 8 that more research must be submitted (testing on the elderly) that the drug wil not cause heart trouble. This is a promising positive step but the jury is still out on the safety of Contrave</p>
]]></content:encoded>
	</item>
</channel>
</rss>
